Loading...

bioAffinity Technologies, Inc.

BIAFW•NASDAQ
Healthcare
Medical - Diagnostics & Research
$0.23
$0.08(55.13%)

bioAffinity Technologies, Inc. (BIAFW) Company Profile & Overview

Explore bioAffinity Technologies, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

bioAffinity Technologies, Inc. (BIAFW) Company Profile & Overview

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOMs. Maria Zannes J.D.

Contact Information

http://www.bioaffinitytech.com
3300 Nacogdoches Road, San Antonio, DE

Company Facts

57 Employees
CountryUS
Actively Trading

Frequently Asked Questions

;